Congo vs Liberia: HIV-positive TB patients on ART (antiretroviral therapy)
Congo
87.0%
in 2024
Liberia
87.0%
in 2024
Congo rank
102nd
Liberia rank
102nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Congo
- Liberia
How they compare
Congo currently reports 87.0% against 87.0% in Liberia, a difference of 0.0%.
The two have swapped places 9 times across 16 shared years of data; in 2008 it was Congo ahead.
Congo ranks 102nd and Liberia ranks 102nd of 144 countries.
Across the 3 decades both report, Congo averaged higher in 1 and Liberia in 2.
Head to head by decade
| Decade | Congo | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.0% | 44.0% | 7.0% | Congo |
| 2010s | 38.7% | 39.7% | 1.0% | Liberia |
| 2020s | 72.8% | 88.6% | 15.8% | Liberia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Congo or Liberia?
- Congo, at 87.0% against 87.0% in Liberia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Congo and Liberia?
- 0.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Liberia?
- 16 years are reported by both, from 2008 to 2024.
- How do Congo and Liberia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Congo ranks 102nd and Liberia ranks 102nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.